GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Guardion Health Science
Glatfelter is a manufacturer of specialty nonwovens. Its stock price reflects its transformation from a traditional paper manufacturer to a supplier of high-tech materials for tea bags, napkins, and hygiene products.
Share prices of companies in the market segment - Pharma eyes
Guardion Health Sciences specializes in the development and sale of nutraceutical products for eye health. We've categorized it as a "Pharma: Eye" company, and the chart below shows how investors value companies at the intersection of dietary supplements and ophthalmology.
Broad Market Index - GURU.Markets
Guardion Health develops and markets dietary supplements and diagnostic tests for eye health. As a unique player, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with Guardion's performance to assess the state of this sector.
Change in the price of a company, segment, and market as a whole per day
GHSI - Daily change in the company's share price Guardion Health Science
Guardion Health Sciences' daily share price fluctuations reflect the high volatility inherent in companies in the dietary supplements sector. This metric measures the company's sensitivity to clinical data and consumer demand for its eye health products.
Daily change in the price of a set of shares in a market segment - Pharma eyes
Guardion Health Sciences develops and markets nutraceuticals for eye health. This sector lies at the intersection of pharmaceuticals and consumer goods. The chart below shows the volatility in this niche, which helps assess the stability or volatility of GHSI's business.
Daily change in the price of a broad market stock, index - GURU.Markets
Guardion Health is a company that produces nutraceuticals for eye health. The company's shares reflect consumer trends in the wellness sector. The dynamics in this sector are part of a larger and more diverse consumer market landscape that influences overall volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Guardion Health Science
For Guardion Health Sciences, year-over-year performance tells the story of its performance in the eye health market. Its market cap change over the past 12 months reflects its success in selling its nutritional supplements and medical products for the diagnosis and treatment of retinal diseases. Its valuation is a bet on its products finding a market.
Annual dynamics of market capitalization of the market segment - Pharma eyes
Guardion, as a company operating in the eye health sector, is betting on aging demographic trends. Its performance relative to the sector will determine how well its products are accepted in the market and how scientific research confirming their effectiveness impacts its performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Guardion Health, with its eye health products, demonstrates how a small company can compete in the dietary supplement market. Its ability to outperform the market depends on the strength of scientific evidence and effective marketing. This is a story of how science can be transformed into a consumer product.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Guardion Health Science
Guardion is a company that produces dietary supplements for eye health. Its monthly performance reflects sales of its core product and its ability to expand distribution. Quarterly revenue reports and consumer trends in the wellness industry are key.
Monthly dynamics of market capitalization of the market segment - Pharma eyes
Guardion Health Sciences focuses on the development and sale of nutraceuticals for eye health. This consumer healthcare sector is growing due to an aging population and increasing screen time. Against this backdrop, Guardion is carving out a niche by offering scientifically based products for vision prevention and support.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Guardion Health Sciences, Inc. is a company specializing in the development and sale of eye health products. Its business depends on the successful marketing and sales of its dietary supplements and medical products. The broader market chart serves as a backdrop to assess how its focus on the niche but stable vision care market has allowed it to move independently of overall sentiment.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Guardion Health Science
Guardion Health Sciences is a company that produces dietary supplements for eye health. Its weekly stock price is driven by consumer demand for its products and the effectiveness of its marketing channels.
Weekly dynamics of market capitalization of the market segment - Pharma eyes
Guardion Health Sciences produces nutraceuticals for eye health. The company's success depends on scientific evidence of its products' effectiveness and consumer demand. The graph will show whether the company is moving with the overall dietary supplement sector or whether its narrow focus on ophthalmology is creating its own market profile.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Guardion is a company in the eye health sector. Its shares likely move based on product news and research, rather than general market trends. The chart will help you assess this independence and volatility.
Market capitalization of the company, segment and market as a whole
GHSI - Market capitalization of the company Guardion Health Science
Guardion Health Sciences' market capitalization reflects its focus on developing nutraceuticals for eye health. Its low valuation and volatility reflect how investors weigh the potential of its products against the challenges of proving their effectiveness and competition in the crowded dietary supplement market.
GHSI - Share of the company's market capitalization Guardion Health Science within the market segment - Pharma eyes
Guardion Health Sciences focuses on developing nutraceuticals for eye health. Its market share in the vast pharmaceutical sector is minimal. Its market capitalization reflects its position as a niche player and the market valuation of its products compared to major vitamin and dietary supplement companies.
Market capitalization of the market segment - Pharma eyes
The graph below shows the market capitalization of the nutraceuticals and dietary supplements sector. Guardion Health Sciences specializes in eye health products. The dynamics of this market reflect the aging population and growing concern for vision. Guardion is seeking to fill its niche by offering science-based supplements to support eye health.
Market capitalization of all companies included in a broad market index - GURU.Markets
Guardion Health develops and markets dietary supplements for eye health. Its market capitalization reflects its focus on this niche market. The chart below shows the economic weight of the specialized nutraceuticals and dietary supplements sector.
Book value capitalization of the company, segment and market as a whole
GHSI - Book value capitalization of the company Guardion Health Science
Guardion Health's core business is its portfolio of brands and inventory of nutraceutical eye care products. This chart tells the story of a small company in the consumer healthcare sector trying to build its brand and core business in the competitive dietary supplement market.
GHSI - Share of the company's book capitalization Guardion Health Science within the market segment - Pharma eyes
Guardion Health Science produces nutraceuticals for eye health. The chart shows its share of tangible assets. These include its R&D centers and manufacturing facilities, where the drugs that form its primary tangible product are created.
Market segment balance sheet capitalization - Pharma eyes
Guardion Health Sciences develops nutraceuticals for eye health. Their business model typically doesn't require owning large factories, relying on contract manufacturing. A chart of their book value shows their focus on R&D and marketing, rather than on heavy manufacturing assets.
Book value of all companies included in the broad market index - GURU.Markets
Guardion Health's assets include laboratories and manufacturing facilities for the creation of nutraceuticals for eye health. The chart shows how the company's resources have evolved over the years, operating in a highly specialized healthcare niche.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Guardion Health Science
Guardion Health Sciences specializes in eye health products. Its value lies in its brand and product formulas. The chart below shows how much the market believes in its ability to carve out a niche in the vast dietary supplement market. The market valuation over book value reflects a premium on marketing and scientific evidence.
Market to book capitalization ratio in a market segment - Pharma eyes
Guardion Health Sciences develops and markets nutraceuticals (dietary supplements) for eye health. The company's valuation depends on clinical data supporting the effectiveness of its products and its ability to build a strong brand. The chart shows how the market evaluates its position in the specialized supplements niche.
Market to book capitalization ratio for the market as a whole
Guardion Health Sciences focuses on eye health products. The company combines scientific research with sales of nutraceuticals. This metric reflects how the market values ββits patents and brand relative to the cost of inventory and equipment. A premium to the market reflects confidence in the effectiveness of its products.
Debts of the company, segment and market as a whole
GHSI - Company debts Guardion Health Science
Guardion Health Sciences is a company specializing in nutraceutical products for eye health. This chart shows the financial strategy of a small company in the dietary supplement sector. It manages its capital to increase sales and brand awareness in the competitive over-the-counter (OTC) market.
Market segment debts - Pharma eyes
Guardion Health Sciences focuses on developing eye health products. The dietary supplement and medical product market is highly competitive. This chart reflects the financial health of a small company trying to carve out a niche in the large healthcare sector.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Guardion Health Science
Guardion Health Sciences produces dietary supplements for eye health. This chart shows its financial structure. In the crowded nutraceutical market, where marketing and consumer trust are crucial, high debt can limit a company's ability to market its product and compete.
Market segment debt to market segment book capitalization - Pharma eyes
Guardion Health Sciences develops nutraceuticals to support eye health. This chart shows the debt burden in the pharmaceutical sector. It helps understand how companies in this highly specialized niche finance their clinical research and marketing to promote their products to consumers and doctors.
Debt to book value of all companies in the market
Guardion Health Sciences focuses on developing nutraceuticals for eye health. The dietary supplement market is competitive and requires scientific evidence and strong marketing. This graph of total market debt allows you to assess how the company finances its clinical research and product developmentβthrough profits or debt.
P/E of the company, segment and market as a whole
P/E - Guardion Health Science
Guardion Health Sciences specializes in the development and sale of nutraceuticals for eye health. This chart shows how investors value the company in the dietary supplement market. This value is based on sales of its products and the results of clinical trials confirming their effectiveness.
P/E of the market segment - Pharma eyes
Guardion Health Sciences is a company specializing in eye health products. It develops and markets dietary supplements and medical products designed to support and protect vision. This chart shows the average valuation for the pharmaceutical sector, reflecting how investors view the nutraceutical and eye health product market.
P/E of the market as a whole
Guardion Health Sciences is a company that develops and markets dietary supplements for eye health. Its valuation is a bet on the growth of the nutraceutical market. This general sentiment graph influences consumer spending, but Guardion prioritizes scientific evidence of its products' effectiveness and its marketing strategy.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Guardion Health Science
Guardion Health Sciences is a company that develops and markets nutraceuticals for eye health. This chart illustrates future revenue expectations, which depend on consumer demand for dietary supplements, marketing effectiveness, and scientific evidence supporting the vision benefits of its products.
Future (projected) P/E of the market segment - Pharma eyes
Guardion Health Sciences specializes in developing and marketing research-based eye health products. This chart shows general expectations for the pharmaceutical sector. The GHSI's position relative to the average reflects market opinion on the clinical efficacy of their dietary supplements and their ability to successfully market them to consumers.
Future (projected) P/E of the market as a whole
Guardion Health Sciences is a company specializing in the development and sale of nutraceutical products for eye health. Its flagship product is designed to replenish protective macular pigment. This chart of general market expectations provides a backdrop for evaluating niche companies in the healthcare sector focused on prevention and healthy living.
Profit of the company, segment and market as a whole
Company profit Guardion Health Science
Guardion Health Sciences specializes in the development and sale of eye health products, including medical nutrition and diagnostic devices. Its financial performance, as shown in the graph, depends on sales of its flagship product, Lumega-Z, and its ability to expand its product line.
Profit of companies in the market segment - Pharma eyes
Guardion Health Sciences specializes in the development and sale of nutraceutical products for eye health. The company's products are aimed at preventing age-related retinal diseases. This chart shows the total revenue in the ophthalmic pharmaceutical sector. It demonstrates the size and profitability of the eye health product market, including both medications and supplements.
Overall market profit
Guardion Health Sciences develops and markets dietary supplements and medical products for eye health. Demand for its products is supported by an aging population and growing health awareness. Economic cycles, visible in this chart, can impact discretionary spending, but underlying demand for vision care products remains relatively stable.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Guardion Health Science
Guardion Health Sciences develops and markets dietary supplements for eye health. The company's profitability depends on sales of its flagship product and marketing effectiveness. This chart shows analysts' future revenue expectations, reflecting their views on the growth of the nutraceutical market and the strength of the company's brand.
Future (predicted) profit of companies in the market segment - Pharma eyes
Guardion Health Sciences develops and markets dietary supplements and medical products for eye health. Demand for the company's products is driven by an aging population and the increasing prevalence of eye diseases. This chart reflects forecasts for the entire pharmaceutical sector, allowing you to assess Guardion Health Sciences' performance in the ophthalmic nutraceuticals niche.
Future (predicted) profit of the market as a whole
Guardion Health Sciences develops and markets eye health products. Demand for dietary supplements and medical products depends on consumer spending on health. This trend, reflecting the overall economic situation, can influence consumers' willingness to spend money on preventative care and non-essential items.
P/S of the company, segment and market as a whole
P/S - Guardion Health Science
Guardion Health Sciences operates in the dietary supplements and eye health products market. This chart shows how investors value its niche products. This trend reflects its ability to grow sales in the competitive nutraceutical market and convince consumers of the effectiveness of its formulas.
P/S market segment - Pharma eyes
Guardion Health Sciences develops and markets dietary supplements and medical products for eye health. Revenue is generated from sales of these nutraceutical products. This chart for the pharmaceutical and supplement sectors helps assess how investors view the scientific validity and market potential of Guardion's products.
P/S of the market as a whole
Guardion Health Sciences is a company specializing in the development and sale of nutraceutical products for eye health. This market revenue valuation chart helps understand how investors value this small player in the dietary supplement market, focused on the ophthalmology niche.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Guardion Health Science
Guardion Health Sciences is a company specializing in the development and sale of nutraceuticals and medical devices for eye health. This chart shows how investors estimate future sales of its products. It reflects their expectations for increased demand for vision supplements driven by an aging population and digital eye strain.
Future (projected) P/S of the market segment - Pharma eyes
Guardion Health Sciences focuses on the development and sale of dietary supplements and medical products for eye health. The company's valuation reflects its attempt to carve out a niche in the ophthalmic nutraceutical market, which is fueled by an aging population but is characterized by high competition and the need to prove product efficacy.
Future (projected) P/S of the market as a whole
Guardion Health Sciences specializes in developing nutraceuticals for eye health. The company's growth is driven by an aging population and the trend toward preventative medicine. This chart illustrates general expectations, and Guardion represents a rapidly growing segment of the consumer health market.
Sales of the company, segment and market as a whole
Company sales Guardion Health Science
Guardion Health Sciences focuses on developing and selling eye health products. This chart shows revenue from sales of its dietary supplements and medical products designed to maintain and improve vision. Demand from the aging population is a significant factor.
Sales of companies in the market segment - Pharma eyes
Guardion Health Sciences (GHSI) is a company specializing in ophthalmology. It develops and markets medical products and nutritional supplements for diagnostics and eye health support. This chart shows revenue in the ophthalmic pharmaceutical sector. Guardion strives to offer comprehensive vision care solutions, from diagnostics to nutritional support.
Overall market sales
Guardion Health Sciences develops and markets dietary supplements for eye health. Demand for its products is driven by demographic trends (aging population) and health awareness. This pattern of overall economic activity influences consumer spending. During periods of growth, people are more willing to invest in their health by purchasing specialized nutraceuticals.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Guardion Health Science
Guardion Health Sciences is a company specializing in the development and sale of nutraceutical products for eye health. Its sales are driven by consumer demand for vision supplements and effective marketing. This chart reflects analyst revenue expectations, which is an indicator of the growth of the ophthalmic supplement market and the popularity of its products.
Future (projected) sales of companies in the market segment - Pharma eyes
Guardion Health Sciences develops nutraceutical products for eye health. This forecast chart details expected sales of their core product. This allows analysts to assess the market potential of their supplements and the company's ability to compete in the vision care market.
Future (projected) sales of the market as a whole
Guardion Health Sciences specializes in developing nutraceuticals for eye health. Demand for its products is driven by an aging population and increasing screen time. This graph shows overall consumer spending on health, and Guardion's sales are an indicator of the growing market for products to prevent age-related eye diseases.
Marginality of the company, segment and market as a whole
Company marginality Guardion Health Science
Guardion Health Sciences focuses on the development and sale of nutraceuticals for eye health. The company's profitability depends on the effectiveness of its products, marketing, and distribution. The chart shows the financial results of the company, which operates in the specialized dietary supplement market, where consumer trust and scientific evidence play a key role.
Market segment marginality - Pharma eyes
Guardion Health Sciences is a company specializing in the development and sale of eye health products, specifically medical nutrition products. This chart shows the company's profitability. Success in this niche depends on scientific evidence of the effectiveness of its products and the ability to communicate their value to ophthalmologists and patients.
Market marginality as a whole
Guardion Health Sciences develops dietary supplements for eye health. Demand for its products depends on consumer awareness and their willingness to spend on preventative care. This overall profitability chart indirectly reflects this willingness. During periods of economic prosperity, people invest more in their health and purchase specialized dietary supplements.
Employees in the company, segment and market as a whole
Number of employees in the company Guardion Health Science
Guardion Health Sciences focuses on developing nutraceuticals and diagnostic tools for eye health. The company offers products to support vision and detect retinal diseases. This graphic shows the small but specialized team working in this niche field at the intersection of pharmaceuticals and nutritional sciences.
Share of the company's employees Guardion Health Science within the market segment - Pharma eyes
Guardion Health Sciences focuses on developing nutraceuticals for eye health. In this niche, success depends on scientifically sound products and effective marketing. This chart shows the staff the company employs for research, formula development, and marketing of its specialized vision support products in the competitive supplement market.
Number of employees in the market segment - Pharma eyes
Guardion Health Sciences develops nutraceuticals for eye health. This chart, reflecting employment in ophthalmic pharmacology, highlights the growing concern about vision problems, including due to an aging population and increased use of gadgets. For Guardion, this means an expanding market for their products aimed at maintaining retinal health.
Number of employees in the market as a whole
Guardion Health Sciences develops and markets nutraceuticals to support eye health. Demand for these specialized dietary supplements depends on consumer awareness and their willingness to spend money on preventative care. The growth in overall employment, as seen in this graph, increases the number of people with a stable income who can afford to invest in their health over the long term.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Guardion Health Science (GHSI)
Guardion Health Science (GHSI) focuses on ophthalmology, specifically dietary supplements for eye health. It is a niche CPG business. This metric reflects how the market values ββtheir brand, patents (if any), and distribution in the medical and consumer segments. It is a balance between R&D and marketing and sales expenditures.
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma eyes
Guardion Health Sciences specializes in eye health products. In niche pharmaceuticals and nutraceuticals, value is determined by product uniqueness and scientific evidence. This chart shows how the market evaluates the company's portfolio and its ability to generate value in its niche.
Market capitalization per employee (in thousands of dollars) for the overall market
Guardion Health Sciences is a company developing nutraceutical products for eye health. It is a niche player in the dietary supplement market. In this graph, its market capitalization per employee reflects the strength of its scientific foundation, brand, and distribution network. This is a competitive market where standing out is difficult.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Guardion Health Science (GHSI)
Guardion Health Science specializes in nutraceuticals (dietary supplements) for eye health. It's a CPG business where success depends on branding and marketing. This chart shows how effectively their small team manages the brand, supply chain, and online sales to generate profits in the competitive dietary supplement niche.
Profit per employee (in thousands of dollars) in the market segment - Pharma eyes
Guardion Health Sciences develops and markets dietary supplements for eye health. In the nutraceutical industry, a balance between scientific research and marketing effectiveness is crucial. This metric demonstrates the revenue generated by each employee, reflecting the company's ability to successfully commercialize its products in a competitive market.
Profit per employee (in thousands of dollars) for the market as a whole
Guardion Health Sciences is a company specializing in nutraceuticals for eye health. They produce and sell dietary supplements (such as Lumega-Z) for vision support. This graph shows the overall market profit margin per employee. It helps understand how the nutraceutical sector, where value is created through branding and marketing, can generate high profit margins per employee.
Sales to employees of the company, segment and market as a whole
Sales per company employee Guardion Health Science (GHSI)
Guardion Health Sciences specializes in eye health products. Revenue per employee reflects the commercial success of its portfolio of ophthalmic nutritional supplements and medical devices. The chart shows how successfully the company sells its products through various channels, from physicians to online platforms, in a large and competitive market.
Sales per employee in the market segment - Pharma eyes
Guardion Health Sciences (GHSI) is a nutraceutical company specializing in the development and sale of eye health products (such as Lumega-Z). This metric reflects the average revenue per employee in the segment. It helps assess how effectively Guardion utilizes its staff to promote and sell its niche dietary supplements.
Sales per employee for the market as a whole
Guardion Health Science (GHSI) is a company specializing in nutraceuticals, primarily for eye health (retinal products). This is a competitive dietary supplement market. This metric reflects how successfully the company sells its products (primarily direct-to-consumer) based on its staff responsible for marketing, R&D, and logistics.
Short shares by company, segment and market as a whole
Shares shorted by company Guardion Health Science (GHSI)
Guardion Health Science (GHSI) is a company specializing in dietary supplements for eye health. This chart shows short interest. The high bearish bets reflect the speculative nature (micro-caps) and investor skepticism about the dietary supplement market, where proving efficacy is difficult and competition from cheaper alternatives is intense. (343)
Shares shorted by market segment - Pharma eyes
Guardion Health Sciences (GHSI) is a company specializing in eye health products, including medical nutrition and diagnostic devices. The chart below shows a general short position in the ophthalmology sector. It reflects investor skepticism about the vision nutraceuticals market.
Shares shorted by the overall market
Guardion Health Science is a microcap stock selling eye health supplements. This chart illustrates the general fear. When investors are pessimistic, they sell off such stocks first. They see GHSI not as a "healthcare" company, but as a producer of niche, non-essential supplements that consumers will easily abandon to save money during a recession.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Guardion Health Science (GHSI)
Guardion Health Science is a nutraceutical company focused on dietary supplements and dietary products for eye health. It's a consumer business. This indicator measures the "temperature" of their quarterly reports. It "warms up" on sales growth data and "cools down" on concerns about intense competition.
RSI 14 Market Segment - Pharma eyes
Guardion Health Sciences is a company specializing in eye health. It develops and markets medical products and dietary supplements (nutraceuticals) for vision support. This chart shows the overall sentiment in the ophthalmic pharmaceutical and nutraceutical sector. It helps understand whether the GHSI trend is a reaction to its products or part of a broader trend.
RSI 14 for the overall market
Guardion Health (GHSI) is a biotech company. Like everything in its sector, it's critically dependent on this schedule. Market euphoria is an opportunity to easily raise hundreds of millions of dollars for research. Market panic is the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast GHSI (Guardion Health Science)
Guardion Health is a company focused on eye health. It develops and sells (primarily direct-to-consumer) nutraceuticals (dietary supplements) designed to support vision and treat dry eye syndrome. This chart shows the analysts' speculative average price target, reflecting their view on e-commerce sales growth in this niche.
The difference between the consensus estimate and the actual stock price GHSI (Guardion Health Science)
Guardion is a nutraceutical for the eyes. The company develops and sells dietary supplements to support retinal health. This chart shows how far the current share price differs from its "fair" value. It reflects analysts' views on the company's ability to grow in the competitive vitamin and supplement market.
Analyst consensus forecast for stock prices by market segment - Pharma eyes
Guardion Health is a nutraceutical company focused on eye health supplements (LUMEVITY). This is a highly competitive market. This chart shows analysts' overall expectations for the eye care sector. It reflects whether experts believe the vision vitamin market is growing or whether they consider it oversaturated.
Analysts' consensus forecast for the overall market share price
Guardion Health Science is a company specializing in eye health. They produce and sell dietary supplements for vision support. This chart shows overall market sentiment. For GHSI, which operates in the competitive dietary supplement sector, overall optimism is important because it reflects consumers' willingness to spend on discretionary fitness and health products.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Guardion Health Science
Guardion Health is an eye pharmacy. They don't do R&D; their focus is selling (D2C, B2B) nutraceuticals (dietary supplements) that (they claim) protect retinal health (macular degeneration). This chart is a summary indicator of their D2C model. It reflects their (meager) sales, their (high) marketing costs, and their (difficult) struggle to survive in the dietary supplement industry.
AKIMA Market Segment Index - Pharma eyes
Guardion Health Science is a company focused on eye health. They produce and sell nutraceuticals (dietary supplements) and medical nutrition products designed to support vision. They're like pharma at the intersection of nutrition and pharmaceuticals. This chart compares their composite index to the sector, showing how their eye supplements compare to the competition.
The AKIM Index for the overall market
Guardion Health Sciences is a clinical nutrition company specializing in eye health (Viactiv, Lumega-Z). It is selling its business. This chart, which reflects the market average, provides a macro backdrop. It helps assess how GHSI, a microcap under liquidation or transformation, compares to the overall macroeconomic situation.